rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
11
|
pubmed:dateCreated |
1997-12-17
|
pubmed:abstractText |
There are limited data on the use of high interferon (IFN) dosage for treatment of children and young adults with hepatitis C virus infection and in those affected by thalassemia major (TM).
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0891-3668
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
16
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1049-53
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9384338-Adolescent,
pubmed-meshheading:9384338-Adult,
pubmed-meshheading:9384338-Autoantibodies,
pubmed-meshheading:9384338-Child,
pubmed-meshheading:9384338-Child, Preschool,
pubmed-meshheading:9384338-Chronic Disease,
pubmed-meshheading:9384338-Female,
pubmed-meshheading:9384338-Ferritins,
pubmed-meshheading:9384338-Genotype,
pubmed-meshheading:9384338-Hepacivirus,
pubmed-meshheading:9384338-Hepatitis C,
pubmed-meshheading:9384338-Humans,
pubmed-meshheading:9384338-Interferon-alpha,
pubmed-meshheading:9384338-Liver,
pubmed-meshheading:9384338-Male
|
pubmed:year |
1997
|
pubmed:articleTitle |
High dosage alpha-interferon for treatment of children and young adults with chronic hepatitis C disease.
|
pubmed:affiliation |
Pediatric Hospital Bambin Gesù, Rome, Italy.
|
pubmed:publicationType |
Journal Article
|